Mechanism of the effects of progesterone and mifepristone on human prostate cancer PC-3 cells
Jiaju Liu
Abstract
Jiaju Liu
Abstract
Objective To explore the mechanism of the effects of progesterone and mifepristone onPC-3 prostate cancer cells. Methods Cell proliferation assays were performed to demonstrate the effectsof progesterone and mifepristone on PC-3 cells.Expression of progesterone receptor gene mRNA was detectedby reverse transcriptase-polymerase chain reaction (RT-PCR) in PC-3 cells.Western blot analysis was em-ployed to show the effects of progesterone and mifepristone on phosphorylation of extracellular signal-regula-ted kinase 1/2 (ERK1/2) in PC-3 cells. Results After 7-d culture, the cell proliferation were signifi-cantly different between normal culture group and drug treatment group (P0.05).The cell number was(1.9±0.2)×105,(3.2±0.3)×105and (1.3±0.2)×105,respectively,in normal culture group,proges-terone (100 nmol/L) group and mifepristone (10μmol/L) group.RT-PCR showed obvious expression ofprogesterone receptor mRNA in PC-3 cells.Western blot showed that phosphorylated (activated) form ofERK1/2 was improved shortly after progesterone added to PC-3 cells.This effect was blocked by mifepristone(10μmol/L) added 1 h before progesterone stimulation.The intensity of p-ERK1/2 band in progesteroneand mifepristone groups was 70752±16377 and 12493±3478,respectively (P0.05). Conclusions Progesterone can improve PC-3 cell proliferation by activation of ERK1/2 pathway;mifepristone can inhibitPC-3 cell proliferation by blockage of progesterone effects on ERK1/2 activation.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the mechanism of the effects of progesterone and mifepristone onPC-3 prostate cancer cells. Methods Cell proliferation assays were performed to demonstrate the effectsof progesterone and mifepristone on PC-3 cells.Expression of progesterone receptor gene mRNA was detectedby reverse transcriptase-polymerase chain reaction (RT-PCR) in PC-3 cells.Western blot analysis was em-ployed to show the effects of progesterone and mifepristone on phosphorylation of extracellular signal-regula-ted kinase 1/2 (ERK1/2) in PC-3 cells. Results After 7-d culture, the cell proliferation were signifi-cantly different between normal culture group and drug treatment group (P0.05).The cell number was(1.9±0.2)×105,(3.2±0.3)×105and (1.3±0.2)×105,respectively,in normal culture group,proges-terone (100 nmol/L) group and mifepristone (10μmol/L) group.RT-PCR showed obvious expression ofprogesterone receptor mRNA in PC-3 cells.Western blot showed that phosphorylated (activated) form ofERK1/2 was improved shortly after progesterone added to PC-3 cells.This effect was blocked by mifepristone(10μmol/L) added 1 h before progesterone stimulation.The intensity of p-ERK1/2 band in progesteroneand mifepristone groups was 70752±16377 and 12493±3478,respectively (P0.05). Conclusions Progesterone can improve PC-3 cell proliferation by activation of ERK1/2 pathway;mifepristone can inhibitPC-3 cell proliferation by blockage of progesterone effects on ERK1/2 activation.
Key concepts: Mifepristone, Progesterone receptor, Western blot, Cell growth, Kinase, Chemistry, Internal medicine, Endocrinology